- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Melphalan-Flufenamide (Melflufen)
Total 956 results
-
U.S. Army Medical Research and Development CommandNaval Medical Research CenterWithdrawn
-
AmgenCompletedMultiple MyelomaKorea, Republic of, China, Spain, Taiwan, United States, Netherlands, Australia, Singapore, New Zealand, United Kingdom, Israel, France, Japan, Italy, Czechia, Belgium, Argentina, Austria, Bulgaria, Canada, Germany, Greece, Hungary, M... and more
-
Duke UniversityCompletedHemoglobinopathies | Thalassemia | Lysosomal Storage Disease | Immunodeficiencies | Inborn Errors of Metabolism | Sickle Cell | Non Malignant Disorders | Congenital Marrow FailuresUnited States
-
Centers for Disease Control and PreventionKamuzu University of Health SciencesCompleted
-
London School of Hygiene and Tropical MedicineMedical Research Council; National Malaria Control Programme, The GambiaCompleted
-
Fondazione EMN Italy OnlusCompleted
-
University of California, San FranciscoTerminatedRetinoblastoma | Advanced Intra-Ocular RetinoblastomaUnited States
-
M.D. Anderson Cancer CenterTerminatedNeuroblastomaUnited States
-
Soonchunhyang University HospitalCompletedNon-hodgkin LymphomaKorea, Republic of
-
Boston Medical CenterTerminatedAL AmyloidosisUnited States
-
National Cancer Institute (NCI)WithdrawnRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Prism Health North TexasMerck Sharp & Dohme LLCWithdrawnObesity | Metabolic Syndrome | Body Weight Changes | Human Immunodeficiency Virus | Fasting | Minority Health | ART | BMDUnited States
-
Nucorion Pharmaceuticals, Inc.Ligand PharmaceuticalsCompletedChronic Hepatitis BUnited States
-
New Discovery LLCUnknownHepatitis B, Chronic | Pregnancy RelatedChina
-
Guenther KoehneNot yet recruitingLeukemia, Myeloid, Acute | Leukemia, Lymphocytic, AcuteUnited States
-
Memorial Sloan Kettering Cancer CenterTerminated
-
Nanfang Hospital of Southern Medical UniversityGuangzhou First People's Hospital; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen... and other collaboratorsUnknownMultiple Myeloma | Conditioning | Autologous Hematopoietic Stem Cell TransplantationChina
-
Samsung Medical CenterMinistry of Health, Republic of KoreaUnknownHigh Risk Neuroblastoma
-
Acorda TherapeuticsMichael J. Fox Foundation for Parkinson's ResearchCompletedIdiopathic Parkinson's DiseaseIsrael, Serbia, United Kingdom
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Completed
-
University of Maryland, BaltimoreKing Pharmaceuticals is now a wholly owned subsidiary of PfizerTerminated
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States, South Africa, Thailand, Botswana, Brazil, Tanzania, Zimbabwe, India, Uganda
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer CenterCompleted
-
German CLL Study GroupCompleted
-
Gesellschaft fur Padiatrische Onkologie und Hamatologie...UnknownNeuroblastomaGermany, Switzerland
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Scotland and Newcastle Lymphoma GroupUnknown
-
Gesellschaft fur Padiatrische Onkologie und Hamatologie...Unknown
-
Christopher StrouseUniversity of IowaRecruiting
-
Masonic Cancer Center, University of MinnesotaCompleted
-
University of Michigan Rogel Cancer CenterMedical College of WisconsinCompletedPhase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple MyelomaMultiple MyelomaUnited States
-
University Hospital TuebingenCompleted
-
Peking University First HospitalRecruiting
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingChronic Lymphoid Leukemia | Large-B-cell Diffuse LymphomaItaly
-
Janssen Research & Development, LLCCompletedHepatitis B, ChronicFrance, Taiwan, Canada, United States, Germany, Spain, Japan, Russian Federation, Turkey, United Kingdom
-
Gilead SciencesActive, not recruitingPre-Exposure Prophylaxis of HIV-1 InfectionUnited States, Austria, Denmark, United Kingdom, Netherlands, Italy, Germany, Canada, Ireland, France, Spain
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingBreast CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
The University of New South WalesCompletedMyelodysplastic Syndromes | LeukemiaUnited Kingdom
-
Children's Cancer and Leukaemia GroupUnknown
-
Yale UniversityCompleted
-
The First Affiliated Hospital with Nanjing Medical...RecruitingNewly Diagnosed Peripheral T-cell LymphomaChina
-
Sidney Kimmel Comprehensive Cancer Center at Johns...RecruitingRefractory and/or Relapsed Metastatic Solid TumorsUnited States
-
Weill Medical College of Cornell UniversityCompletedMyelodysplastic Syndromes | Leukemia, Erythroblastic, AcuteUnited States
-
Fate TherapeuticsDana-Farber Cancer InstituteCompletedHematologic Malignancies | Allogeneic Stem Cell TransplantationUnited States
-
Stanford UniversityOrca Biosystems, Inc.RecruitingMyelodysplastic Syndromes | Myeloproliferative Disorders | Acute Leukemia | Chronic Myelogenous Leukemia | Allogeneic Hematopoietic Cell Transplantation (HCT) | Advanced Hematologic MalignanciesUnited States
-
Roswell Park Cancer InstituteActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Platinum-Sensitive Ovarian Carcinoma | Refractory Ovarian... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingPrimary Myelofibrosis | Acute Leukemia | Myelodysplastic Syndrome | Secondary Myelofibrosis | Hematologic and Lymphocytic DisorderUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingHematologic MalignanciesUnited States